📊 RBOTW Key Takeaways
Is Vicarious Surgical Inc. (RBOTW) a Good Investment?
Vicarious Surgical is a pre-revenue or near-zero revenue company burning approximately $45M in operating cash annually against only $2.6M in cash reserves, creating a critical liquidity crisis. With persistent operating losses of $50M, negative profitability across all metrics, and a cash runway of less than one month at current burn rates, the company faces imminent insolvency without significant capital infusion or immediate path to profitability.
Why Buy Vicarious Surgical Inc. Stock? RBOTW Key Strengths
- Low debt-to-equity ratio of 0.20x provides limited financial flexibility
- Operates in surgical supplies sector (SIC 3842) with long-term market potential
- Current ratio of 2.97x indicates adequate short-term asset coverage on balance sheet
RBOTW Stock Risks: Vicarious Surgical Inc. Investment Risks
- No revenue generation reported - company appears pre-commercial or non-viable
- Catastrophic cash burn of $45.1M operating cash flow against $2.6M cash on hand (sub-one-month runway)
- Persistent $50M+ operating losses with zero path to profitability demonstrated
- Negative ROE (-509.9%) and ROA (-256.3%) indicate severe asset utilization failure
- EPS deteriorated 1,325% YoY, signaling worsening financial condition
- Minimal insider activity (2 filings/90 days) suggests limited management confidence
Key Metrics to Watch
- Days of cash remaining and any capital raise announcements
- Quarterly revenue achievement or first revenue milestone
- Operating cash burn rate trajectory and path to cash flow positive
- Form 8-K filings for material adverse changes or going concern warnings
Vicarious Surgical Inc. (RBOTW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.97x current ratio provides a solid financial cushion.
RBOTW Profit Margin, ROE & Profitability Analysis
RBOTW vs Healthcare Sector: How Vicarious Surgical Inc. Compares
How Vicarious Surgical Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Vicarious Surgical Inc. Stock Overvalued? RBOTW Valuation Analysis 2026
Based on fundamental analysis, Vicarious Surgical Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Vicarious Surgical Inc. Balance Sheet: RBOTW Debt, Cash & Liquidity
RBOTW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Vicarious Surgical Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.04 reflects profitable operations.
RBOTW Revenue Growth, EPS Growth & YoY Performance
Vicarious Surgical Inc. Dividends, Buybacks & Capital Allocation
RBOTW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Vicarious Surgical Inc. (CIK: 0001812173)
📋 Recent SEC Filings
❓ Frequently Asked Questions about RBOTW
What is the AI rating for RBOTW?
Vicarious Surgical Inc. (RBOTW) has an AI rating of STRONG SELL with 96% confidence, based on fundamental analysis of SEC EDGAR filings.
What are RBOTW's key strengths?
Claude: Low debt-to-equity ratio of 0.20x provides limited financial flexibility. Operates in surgical supplies sector (SIC 3842) with long-term market potential.
What are the risks of investing in RBOTW?
Claude: No revenue generation reported - company appears pre-commercial or non-viable. Catastrophic cash burn of $45.1M operating cash flow against $2.6M cash on hand (sub-one-month runway).
What is RBOTW's revenue and growth?
Vicarious Surgical Inc. reported revenue of N/A.
Does RBOTW pay dividends?
Vicarious Surgical Inc. does not currently pay dividends.
Where can I find RBOTW SEC filings?
Official SEC filings for Vicarious Surgical Inc. (CIK: 0001812173) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RBOTW's EPS?
Vicarious Surgical Inc. has a diluted EPS of $-5.49.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is RBOTW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Vicarious Surgical Inc. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is RBOTW stock overvalued or undervalued?
Valuation metrics for RBOTW: ROE of -509.9% (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy RBOTW stock in 2026?
Our dual AI analysis gives Vicarious Surgical Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RBOTW's free cash flow?
Vicarious Surgical Inc.'s operating cash flow is $-45.1M, with capital expenditures of $132.0K.
How does RBOTW compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE -509.9% (avg: 15%), current ratio 2.97 (avg: 2).